Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)

TWD 15.25

(-3.17%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 748.57 Million 706.77 Million 713.74 Million 823.44 Million 655.06 Million
Total Current Assets 259.29 Million 260.13 Million 267.65 Million 347.34 Million 220.08 Million
Cash And Short Term Investments 182.13 Million 158.55 Million 159.69 Million 236.89 Million 106.25 Million
Cash and Cash Equivalents 182.13 Million 158.55 Million 159.69 Million 236.89 Million 106.25 Million
Short Term Investments -75.21 Million -47.71 Million -49.19 Million -51.13 Million -
Net Receivables 54.83 Million 76.37 Million 81.51 Million 84.89 Million 50.47 Million
Inventory 21.17 Million 23.42 Million 24.11 Million 25.01 Million 26.34 Million
Other Current Assets 1.15 Million 1.77 Million 2.33 Million 551 Thousand 37.01 Million
Total Non-Current Assets 489.27 Million 446.64 Million 446.08 Million 476.1 Million 434.98 Million
Net PPE 247.5 Million 256.25 Million 259.07 Million 271.44 Million 226.7 Million
Good Will And Intangible Assets 216 Thousand 3.53 Million 10.14 Million 24.06 Million 30.47 Million
Good Will - - - - -
Intangible Assets 216 Thousand 3.53 Million 10.14 Million 24.06 Million 30.47 Million
Long-Term Investments 169.11 Million 120.64 Million 116.94 Million 116.83 Million -
Tax Assets 9.81 Million 8.82 Million 8.73 Million 13.07 Million -
Other Non Current Assets 62.62 Million 57.38 Million 51.18 Million 50.68 Million 177.81 Million
Other Assets - - - - -
Total Liabilities 514.65 Million 462.12 Million 472.29 Million 464.55 Million 270 Thousand
Total Current Liabilities 316.82 Million 243.06 Million 245.07 Million 215.95 Million 182.99 Million
Account Payables 3.75 Million 3.45 Million 4.26 Million 6.58 Million 16.75 Million
Tax Payables - - - - -
Short Term Debt 233.24 Million 182.39 Million 140.47 Million 147.28 Million 112.1 Million
Deferred Revenue 74.8 Million 53.58 Million 95.2 Million 59.32 Million -
Other Current Liabilities 5.01 Million 3.62 Million 5.14 Million 2.75 Million 54.12 Million
Total Non Current Liabilities 197.83 Million 219.06 Million 227.21 Million 248.6 Million 270 Thousand
Long-Term Debt 86.89 Million 108.39 Million 115.78 Million 127.1 Million 156.25 Million
Deferred Revenue Non Current 109.07 Million 109.06 Million 109.62 Million 117.21 Million -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 889 Thousand 1.6 Million 110 Thousand 110 Thousand -155.98 Million
Other Liabilities - - - - -182.99 Million
Total Equity 233.92 Million 244.64 Million 241.45 Million 358.89 Million 195.2 Million
Stock Holders Equity 233.92 Million 244.64 Million 241.45 Million 358.89 Million 195.2 Million
Common Stock 900 Million 900 Million 900 Million 900 Million 800 Million
Retained Earnings -665.72 Million -654.95 Million -658.59 Million -691.1 Million -704.79 Million
Accumulated other comprehensive income -358 Thousand -402 Thousand - - -
Common Stock Equity 233.92 Million 244.64 Million 241.45 Million 358.89 Million 195.2 Million
Capital Lease Obligation 7.54 Million 9.77 Million 12.1 Million 20.58 Million 23.21 Million
Total Investments 93.89 Million 72.93 Million 67.75 Million 65.69 Million -
Total Debt 320.13 Million 290.79 Million 256.25 Million 274.38 Million 268.36 Million
Net Debt 137.99 Million 132.23 Million 96.56 Million 37.49 Million 162.11 Million

Balance Sheet Charts